AngioDynamics, Inc. (ANGO)
NASDAQ: ANGO · Real-Time Price · USD
13.15
-0.33 (-2.45%)
At close: Dec 17, 2025, 4:00 PM EST
13.15
0.00 (0.00%)
After-hours: Dec 17, 2025, 5:38 PM EST
AngioDynamics Employees
AngioDynamics had 675 employees as of May 31, 2025. The number of employees decreased by 73 or -9.76% compared to the previous year.
Employees
675
Change (1Y)
-73
Growth (1Y)
-9.76%
Revenue / Employee
$445,508
Profits / Employee
-$47,553
Market Cap
541.78M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 675 | -73 | -9.76% |
| May 31, 2024 | 748 | -67 | -8.22% |
| May 31, 2023 | 815 | 55 | 7.24% |
| May 31, 2022 | 760 | -40 | -5.00% |
| May 31, 2021 | 800 | 0 | - |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ANGO News
- 5 weeks ago - AngioDynamics, Inc. (ANGO) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 7 weeks ago - AngioDynamics to Participate in the UBS Global Healthcare Conference - Business Wire
- 2 months ago - AngioDynamics' NanoKnife® System Named to TIME's 2025 Best Inventions List - Business Wire
- 2 months ago - AngioDynamics: Discounted Sales Multiple With Real Growth Engines - Seeking Alpha
- 2 months ago - AngioDynamics, Inc. (ANGO) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Nasdaq Surges 100 Points; AngioDynamics Posts Upbeat Q1 Results - Benzinga
- 2 months ago - AngioDynamics Reports Fiscal Year 2026 First Quarter Financial Results; Med Tech Growth of 26.1% Drives Continued Momentum - Business Wire
- 2 months ago - Top Wall Street Forecasters Revamp AngioDynamics Expectations Ahead Of Q1 Earnings - Benzinga